TCF7L1 and gastric cancer: Mechanistic studies demonstrated that TCF7L1 could negatively regulate Keap1 expression and the resultant NRFF2 stability, which positively regulates redox balance and aerobic glycolysis that promote proliferation of gastric cancer cells in patients (Fig. 7).